George McLaughlin

George McLaughlin
George serves as Redox's creative director which means he writes a lot and comes up with whacky ideas in meetings.
Find me on:

Recent Posts

HIMSS 2017 Party List

Posted by George McLaughlin on Feb 20, 2017 11:42:31 AM

In my best Bruce Buffer voice—“ladies and gentlemen, it’s TIME!”


Badass Women in Health Tech: Breanna Cunningham, CEO of CODE Technology

Posted by George McLaughlin on Feb 8, 2017 9:16:07 AM

It's a distinct pleasure to share my recent interview with one of Redox's favorite people in health tech, Breanna Cunningham. From day one, Breanna has impressed our team with her infectious energy and amazing ability to execute. Join us as we learn about her path from trauma ICU nurse to CEO of the rapidly growing CODE Technology.


Is FDA Approval the Secret to Digital Health Application Success?

Posted by George McLaughlin on Feb 2, 2017 9:40:01 AM

From day one, Redox has been passionate about supporting the “little guys”. So much of what we do is purposefully designed to allow anyone with a great idea or product to penetrate the healthcare market and deliver beneficial solutions to patients and providers.


Why We Write

Posted by George McLaughlin on Jan 31, 2017 9:50:15 AM

We’ve made a conscious effort over the last few months to share our views, far beyond our product and services. The question you might be asking yourself is "why?". What does an article on women’s representation in health tech have to do with Redox? With integration?


Badass Women in Health Tech: Bronwyn Spira, Founder & CEO of FORCE Therapeutics

Posted by George McLaughlin on Jan 23, 2017 1:35:03 PM

What does it take to be a successful woman in healthcare technology?

CES2017 Friday Recap: Healthcare Goes Virtual

Posted by George McLaughlin on Jan 7, 2017 4:10:58 PM

Whew. To say my head is spinning is an understatement. CES so far has been a sensory and information overload the likes of which I have never experienced*.


Health and Technology in Las Vegas

Posted by George McLaughlin on Jan 5, 2017 2:30:27 PM

I'm about to fly to Las Vegas for CES 2017 and I have no idea what to expect.


7 Bold Predictions for Healthcare in 2017

Posted by George McLaughlin on Dec 8, 2016 4:26:41 PM

With the new year fast approaching, we took some time to think about the future of healthcare and predict what significant stories we'll see play out over the next year. Join us as we gaze into our snow covered crystal ball (it’s cold here in Wisconsin) for seven bold healthcare predictions for 2017.


Getting to Know HHS and CMS Appointees Tom Price and Seema Verma

Posted by George McLaughlin on Nov 29, 2016 9:14:22 PM

Donald Trump has made public his appointees for Secretary of Health and Human Services (HHS) and Administrator of the Centers for Medicare and Medicaid Services (CMS).

Ladies and gentlemen, please acquaint yourselves with six-term Republican Congressman (GA), David Price, and high flying healthcare consultant, Seema Verma.


What We're Thankful For

Posted by George McLaughlin on Nov 23, 2016 9:39:57 AM

Thanksgiving is upon us! To kick off the holiday season I polled the Redox office with a simple question: "What are you thankful for?"


Joe Biden Just Gave the Most Inspiring Speech You Will Hear All Year

Posted by George McLaughlin on Oct 24, 2016 3:17:56 PM

“To the clinicians in the room, how many times has a patient looked you in the eye and said:

‘Doc, can you just give me two more weeks? I want to walk her down the aisle.’
‘Can you give me another month? He’s graduating.’
‘My daughter’s about to deliver our first grandchild, let me see it, please let me be there.’

They aren’t asking to live. They aren’t asking to be cured. They’re asking for one more moment and it matters. It matters a lot. Every damn moment counts and every moment we delay matters.” 

- Joe Biden, October 24th, 2016, Cleveland Clinic Medical Innovation Summit


Improving Diabetes Research & Treatment with Clinical Data Integration

Posted by George McLaughlin on Oct 24, 2016 11:48:15 AM

1 in 11 people worldwide live with diabetes. That’s over 415 million people suffering from a life-threatening disease that is also the leading cause of cardiovascular disease, blindness, kidney failure, and lower-limb amputation. While decades of research and treatment have lead to enormous improvements in both prevention and treatment, the disease, which already represents 12% of the world’s health expenditure (~$673 billion!), is growing at a frightening rate. If advancements in prevention and efficiency gains in treatment aren’t made quickly, the world risks a staggering numbers of lives lost, as well as dire financial ramifications that could threaten the stability of countries worldwide.


Subscribe to Email Updates